Non-nutritive Sweeteners in Inflammatory Bowel Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity Hospitals Cleveland Medical Center

About this trial

This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with IBD, compared to healthy non-IBD individuals. We will focus on studying IBD patients affected with CD as a proof of principle that could be tested later in other IBD subtype (ulcerative colitis or others specific surgical conditions).

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Sucralose (non-nutritive sweetener)

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Hospitals Cleveland Medical Center

Lead sponsor

Crohn's and Colitis Foundation

Collaborator